title: Adjuvant treatment with topical 5% imiquimod cream for resected stage IIIb melanoma.
authors.forename: Danica
authors.initials: D
authors.lastname: Tiodorovic-Zivkovic
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Argenziano
authors.forename: Caterina
authors.initials: C
authors.lastname: Catricalà
authors.forename: Gerardo
authors.initials: G
authors.lastname: Ferrara
authors.forename: Caterina M
authors.initials: CM
authors.lastname: Giorgio
authors.forename: Elvira
authors.initials: E
authors.lastname: Moscarella
authors.forename: Iris
authors.initials: I
authors.lastname: Zalaudek
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000287:Administration, Topical; D000634:Aminoquinolines / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D000077271:Imiquimod; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D009367:Neoplasm Staging; D009824:Ointments / Q000008:administration & dosage; D012535:Scalp; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
chemical_list: D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D009824:Ointments; D000077271:Imiquimod